Critical appraisal:Broer PN, Walker ME, Goldberg C, Buonocore S, Braddock DT, Lazova R, et al 2013 2

From Cancer Guidelines Wiki

Risk of bias assessment: cohort study

Subject selection
"New technology" group
Highly selected or not described
Comparison group
Selected group
Comparability of groups on demographic characteristics and clinical features
Not comparable and not adjusted for differences
Measurement of outcomes
Outcome measures blind to technology used
No, but objective measures used
Same method of measurement used across comparison groups
Yes
Completeness of follow-up
Was follow-up complete and were all patients included in the analysis?
Yes (follow-up >95%) or survival analysis using all patients
Overall risk of bias
High risk of bias Additional comments: Please replace this text and include any additional comments in regards to your risk of bias rating


Jutta's tick icon.png This appraisal has been completed.


Article
Broer PN, Walker ME, Goldberg C, Buonocore S, Braddock DT, Lazova R, et al. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy. Eur J Surg Oncol 2013 Jul;39(7):681-5 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23522951.
Assigned to
User:Cecilia.taing
Topic area
Guidelines:Melanoma
Clinical question
Form
Form:Quality appraisal cohort


Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Critical_appraisal:Broer_PN,_Walker_ME,_Goldberg_C,_Buonocore_S,_Braddock_DT,_Lazova_R,_et_al_2013_2&oldid=166705"